Almirall Will Sell Basilea's Eczema Drug In 10 European Markets, Plus Mexico
This article was originally published in The Pink Sheet Daily
Executive Summary
The company's distribution agreement with Almirall does not change Basilea's 2010 sales guidance for its eczema drug Toctino, execs said.